Therefore, when fever occurs early after CAR-T cell infusion, CRS should be considered first for patients with acute lymphoblastic leukemia and lymphoma, and the changes of peripheral oxygen concentration, blood pressure, organ function, and blood biological markers (IL-6, CRP, and ferritin, etc.)should be monitored more frequently. This evidence concerns the gene CRP and lymphoma.